Cancer and Leukemia Group B (CALGB) Research Base — Chicago, Illinois

Cancer and Leukemia Group B (CALGB) Research Base is a clinical research site located in Chicago, Illinois, United States 60604-1104.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Cancer and Leukemia Group B (CALGB) Research Base has participated in 2 clinical trials.

Therapeutic areas: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer and Leukemia Group B (CALGB) Research Base?

Cancer and Leukemia Group B (CALGB) Research Base has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer and Leukemia Group B (CALGB) Research Base conducted?

Cancer and Leukemia Group B (CALGB) Research Base has 2 clinical trials on record. Their work covers Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma.

Is Cancer and Leukemia Group B (CALGB) Research Base accredited by Crixeo Health?

Cancer and Leukemia Group B (CALGB) Research Base has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer and Leukemia Group B (CALGB) Research Base?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.